T. Rowe Price Associates
AGRX

T. Rowe Price Associates’s Agile Therapeutics AGRX Stock Holding History

T. Rowe Price Associates’s Portfolio AGRX Stock Details AGRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
2021
Q4 		$21K Hold
2021
Q3 		$41K Sell
2021
Q2 		$110K Sell
2021
Q1 		$182K Buy
2020
Q4 		$131K Buy
2020
Q3 		$40K Buy
2017
Q1 		– Sell
2016
Q4 		$158K Hold
2016
Q3 		$194K Sell
2016
Q2 		$313K Buy